As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Guardian Pharmacy Services Inc. The largest reported stake is Bindley Capital Partners I, LLC's, at 26.4%. 16 filings are on record since July 17, 2025 (Schedule 13D/A, September 28, 2026).
Sell to companies like Guardian Pharmacy Services Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Fmr LLC · Sole voting: 3,138,341 · Shared voting: 0 · Sole dispositive: 3,138,459 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-11-05
- · Reporting person: Bindley Capital Partners I, LLC · Sole voting: 16,669,666 · Shared voting: 0 · Sole dispositive: 16,669,666 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-09-28
- · Holder: Fmr LLC · Percent: 6.5% · SCHEDULE 13G
- · Holder: Bindley Capital Partners I, LLC · Percent: 21.3% · SCHEDULE 13D/A
- · Holder: Brown Advisory Inc · Percent: 4.54% · SCHEDULE 13G/A
Guardian Pharmacy Services Inc has 16 Schedule 13D or 13G filings on record since 2025-07-17. 2 holders' latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 26.4% | 16,669,666 | SCHEDULE 13D/A, 2026-09-28 | 2026-09-27 |
| Fmr LLC | 5% | 3,138,459 | SCHEDULE 13G/A, 2026-11-05 | 2026-09-30 |
| Brown Advisory Inc | 4.54% | 1,644,569 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Franklin Resources, Inc. | 4.3% | 976,207 | SCHEDULE 13G/A, 2025-08-05 | 2025-06-30 |
| The Vanguard Group | 4.25% | 966,806 | SCHEDULE 13G/A, 2025-07-29 | 2025-06-30 |
| BlackRock, Inc. | 4.2% | 1,507,822 | SCHEDULE 13G/A, 2026-01-21 | 2025-12-31 |
| Wellington Management Group LLP | 3.1% | 1,123,132 | SCHEDULE 13G/A, 2026-02-10 | 2025-12-31 |
| J. Goldman & Co LP | 2.9% | 656,860 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Clearbridge Investments, LLC | 2% | 445,524 | SCHEDULE 13G/A, 2025-08-05 | 2025-06-30 |
Holding shares or following this stake? See who's behind Guardian Pharmacy Services Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Guardian Pharmacy Services Inc and the records around it.
Guardian Pharmacy Services Inc elsewhere on the record
- Leadership changes Jun 2026
- Who owns it
Companies that share a holder
- Clearbridge Investments, LLC also filed stake reports on 4 other companies: Brookfield Renewable Corp (Nov 2026), Clearway Energy, Inc. (Nov 2026), Rice Acquisition Corp 3 (Feb 2026)
- BROWN ADVISORY INC also filed stake reports on 11 other companies: Andersen Group Inc. (Oct 2026), Lumexa Imaging Holdings, Inc. (Aug 2026), Nomad Foods Ltd (Aug 2026)
- J. Goldman & Co LP also filed stake reports on 11 other companies: Andersen Group Inc. (Aug 2026), Grocery Outlet Holding Corp. (Aug 2026), Daedalus Special Acquisition Corp. (May 2026)
Watch Guardian Pharmacy Services Inc
Get an email when Guardian Pharmacy Services Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Guardian Pharmacy Services Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Guardian Pharmacy Services Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Guardian Pharmacy Services Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 16,669,666 | 0 | 16,669,666 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| William E. Bindley | 0 | 16,669,666 | 0 | 16,669,666 | SCHEDULE 13D/A, 2026-09-28 |
| Thomas J. Salentine, Jr. | 35,714 | 16,669,666 | 35,714 | 16,669,666 | SCHEDULE 13D/A, 2026-09-28 |
| Pharmacy Investors, LLC | 3,863,806 | 0 | 3,863,806 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| John Ackerman | 3,863,806 | 0 | 3,863,806 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| Cardinal Equity Fund, L.P. | 1,287,237 | 0 | 1,287,237 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| Fred P. Burke | 3,438,064 | 0 | 3,438,064 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| David K. Morris | 877,004 | 0 | 877,004 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| G. Kendall Forbes | 1,651,059 | 0 | 1,651,059 | 0 | SCHEDULE 13D/A, 2026-09-28 |
| Fmr LLC | 3,138,341 | 0 | 3,138,459 | 0 | SCHEDULE 13G/A, 2026-11-05 |
| Abigail P. Johnson | 0 | 0 | 3,138,459 | 0 | SCHEDULE 13G/A, 2026-11-05 |
The latest filing identifies Guardian Pharmacy Services Inc by CUSIP 40145W101 and gives its principal executive office as 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA, GA 30339 (SCHEDULE 13G/A, 2026-11-05).
Source of funds (Item 3)
As of the date hereof, the Reporting Persons, collectively, beneficially own 27,822,550 shares of Class A common stock.Bindley Capital Partners I, LLC, SCHEDULE 13D/A, 2026-09-28
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 4% | SCHEDULE 13G/A |
| 2025-07-29 | The Vanguard Group | 4.25% | SCHEDULE 13G/A |
| 2025-07-29 | Bindley Capital Partners I, LLC | 22.3% | SCHEDULE 13D/A |
| 2025-08-05 | Franklin Resources, Inc. | 4.3% | SCHEDULE 13G/A |
| 2025-08-05 | Clearbridge Investments, LLC | 2% | SCHEDULE 13G/A |
| 2025-08-12 | Wellington Management Group LLP | 4.9% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2025-11-12 | Wellington Management Group LLP | 5% | SCHEDULE 13G |
| 2025-11-14 | J. Goldman & Co LP | 2.9% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock, Inc. | 4.2% | SCHEDULE 13G/A |
| 2026-02-10 | Wellington Management Group LLP | 3.1% | SCHEDULE 13G/A |
| 2026-02-13 | Brown Advisory Inc | 4.54% | SCHEDULE 13G/A |
| 2026-03-24 | Bindley Capital Partners I, LLC | 21.3% | SCHEDULE 13D/A |
| 2026-05-06 | Fmr LLC | 6.5% | SCHEDULE 13G |
| 2026-09-28 | Bindley Capital Partners I, LLC | 26.4% | SCHEDULE 13D/A |
| 2026-11-05 | Fmr LLC | 5% | SCHEDULE 13G/A |
Questions about who owns Guardian Pharmacy Services Inc
Who owns Guardian Pharmacy Services Inc?
On this page, 2 holders' latest ownership filings report 5% or more of Guardian Pharmacy Services Inc: Bindley Capital Partners I, LLC (26.4%, Schedule 13D/A, filed 2026-09-28) and Fmr LLC (5%, Schedule 13G/A, filed 2026-11-05).
Who are the largest shareholders of Guardian Pharmacy Services Inc?
By the share each holder's latest filing reports, the largest holders of Guardian Pharmacy Services Inc on this page are Bindley Capital Partners I, LLC (26.4%) and Fmr LLC (5%).
When did Bindley Capital Partners I, LLC buy into Guardian Pharmacy Services Inc?
The filings give report dates, not purchase dates. The earliest filing from Bindley Capital Partners I, LLC on this page is the Schedule 13D/A, filed 2025-07-29, reporting 22.3%; its latest, Schedule 13D/A filed 2026-09-28, reports 26.4%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 16 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Guardian Pharmacy Services Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 22, 2026 | Leadership change: Will Mudd appointed, Chief Financial Officer | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Guardian Pharmacy Services Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.